Cryptic array findings among those patients comprised large-scale UPD (up to 118 Mb) and genomic deletion of loci implicated in MDS pathogenesis (eg, TET2 (4q22) and NUP98 (11p15)). The gene discussed is TET2; the disease is myelodysplastic syndrome.